Peer Review History
| Original SubmissionApril 25, 2025 |
|---|
|
Dear Dr. Michel, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 24 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Tomasz W. Kaminski Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Thank you for stating in your Funding Statement: [This research was supported by the Max Planck Society (www.mpg.de)]. Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: [This research was supported by the Max Planck Society. We are grateful to the infants and parents who participated.] We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: [This research was supported by the Max Planck Society (www.mpg.de)]. Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. We note that Figure 1 includes an image of a participant in the study. As per the PLOS ONE policy (http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research) on papers that include identifying, or potentially identifying, information, the individual(s) or parent(s)/guardian(s) must be informed of the terms of the PLOS open-access (CC-BY) license and provide specific permission for publication of these details under the terms of this license. Please download the Consent Form for Publication in a PLOS Journal (http://journals.plos.org/plosone/s/file?id=8ce6/plos-consent-form-english.pdf). The signed consent form should not be submitted with the manuscript, but should be securely filed in the individual's case notes. Please amend the methods section and ethics statement of the manuscript to explicitly state that the patient/participant has provided consent for publication: “The individual in this manuscript has given written informed consent (as outlined in PLOS consent form) to publish these case details”. If you are unable to obtain consent from the subject of the photograph, you will need to remove the figure and any other textual identifying information or case descriptions for this individual. 5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Dear Authors, Thank you for your patience during the review process. I apologize for the delay - the topic is highly specialized, and it took time to secure input from the appropriate experts in the field. Both reviewers have now submitted their comments, and I’m pleased to inform you that both recommend minor revisions, which is also in line with my own assessment of the manuscript. At this point, I invite you to revise your manuscript by addressing the reviewers’ comments carefully and thoroughly. Once your revised version is submitted, we will proceed with the next steps. Please don’t hesitate to reach out if you have any questions. Best regards, Tomasz W. Kaminski [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: The authors investigate whether pupil dilation in infants serves as a marker of expectation violation (VOE) by presenting four different paradigms. They hypothesized that unexpected events would elicit greater pupil dilation. The results did not support this hypothesis and thus suggests that pupil dilation may not be a good way to estimate VOE. Overall, the manuscript addresses a relevant question and is well written. There are several methodological ambiguities and analytical choices that require clarification or further justification. In addition I suggest a few minor edits 1. Lack of Support for Hypothesis and Framing of Results: The authors conclude that they did not find “strong evidence” for pupil dilation during VOE. However, the data rather suggest evidence against such an effect. The wording in the conclusion should be revised to reflect this interpretation, while acknowledging that the absence of evidence is not evidence of absence (which the authors already do) 2. Unclear Participant Breakdown and EEG Subsample: The authors should clarify the samples used for the different analyses. How many infants participated in the VOE, how many wore EEG caps, was there an overlap? Right now the authors write that the sample included 65 infants and that 3 were excluded. But then they write that the pre-registered protocol included 30, but that only 21 were sampled. I am confused. 3. Justification of Analytical Methods: I am not familiar with the curve analysis applied in addition to the pre-registered mixed ANOVA is not a standard approach in this context. The rationale for using this analysis should be explained more clearly, especially since it forms a central part of the authors’ interpretation. 4. Effect Sizes Missing: The manuscript would benefit from consistent inclusion of effect size estimates to help contextualize the findings and support claims of null or small effects. 5. Table 1 Redundancy: The information in Table 1 could be integrated into the main text, as it currently seems superfluous. 6. Figure Legibility: Several figures could benefit from higher resolution and adjustment of fonts. For figure 4 the font seems too small and figure 3 seems very pixelated. (Perhaps this is only in this version?). 7. Stimulus Visibility to Parents: It would be helpful to clarify whether the sunglasses used to occlude parental vision fully prevented them from seeing the stimuli, as this may affect the infant’s behavior. Reviewer #2: Dear Authors, I would like to congratulate you on a novel and well-executed study. Your preregistered and methodologically rigorous investigation addresses an important and timely question regarding the suitability of pupil dilation as a marker of violation-of-expectation (VOE) responses in infancy. Below, I offer a few substantive suggestions that I believe could further strengthen your manuscript: 1. Strengthen the theoretical rationale for expecting domain-general VOE effects in pupil dilation While you refer to previous EEG findings (Köster et al., 2018) and arousal-based explanations, the theoretical basis for expecting domain-general effects in pupil dilation remains underdeveloped. I suggest expanding on why pupil dilation should be sensitive to violations across diverse knowledge domains (e.g., action, cohesion, number, solidity), potentially by integrating predictive processing theories or broader arousal/surprise frameworks in infancy. A clearer mechanistic link between expectation violation and pupillary response would help frame your study's goals and findings. 2. Add a clearer and more detailed description of the statistical analysis The manuscript currently lacks a concise summary of the statistical analysis pipeline in the main text. While the specification curve is discussed in the results and supplemental sections, the main paper would benefit from a clearer outline of the core analytical steps and decision points, particularly regarding how the pupil dilation data were processed, analyzed, and interpreted. This would enhance transparency and reproducibility. 3. Clarify the theoretical implications of the null result The discussion could more fully engage with what the null findings mean for the field. I recommend addressing two possible interpretations: (a) that pupil dilation may not serve as a reliable index of VOE at 9-10 months, and/or (b) that domain-general VOE effects themselves may be less robust or not yet fully developed at this age. Framing your null results in the context of broader theories of cognitive surprise, arousal, or predictive learning in infancy would increase the theoretical value of your findings and avoid the perception of inconclusiveness. 4. Provide a clearer take-home message The manuscript would benefit from a more conclusive final paragraph that distills the contribution of your findings. For instance, you might emphasize that while pupillometry is a promising tool, it may not reliably detect domain-general VOE effects in infancy, at least under the current task parameters. Consider adding a statement such as: “Our findings suggest that while pupillometry offers methodological advantages, it may not serve as a reliable standalone indicator of domain-general VOE responses in infants under one year. This calls for caution in interpreting null or inconsistent pupil-based findings in early infancy and underscores the need for multi-modal approaches.” Again, I commend the authors for a carefully designed and transparently reported study. I hope these suggestions are constructive and help enhance the clarity and theoretical contribution of the manuscript. Sincerely, Reviewer ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Anders Rasmussen Reviewer #2: Yes: Wolosowicz Marta ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 1 |
|
No clear evidence for a domain-general violation of expectation effect in the pupillary responses of 9- to 10-month-olds PONE-D-25-21638R1 Dear Dr. Michel, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Tomasz W. Kaminski Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .